Edgewise Therapeutics, Inc. (EWTX)
24.16
-0.74
(-2.97%)
USD |
NASDAQ |
Jan 12, 11:00
Edgewise Therapeutics Research and Development Expense (Annual): 124.90M for Dec. 31, 2024
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Dynavax Technologies Corp. | 61.55M |
| Omeros Corp. | 119.52M |
| Gilead Sciences, Inc. | 5.816B |
| Agios Pharmaceuticals, Inc. | 295.63M |
| NovaBay Pharmaceuticals, Inc. | 0.042M |